#direct-acting antivirals

No significant links were found between liver stiffness prior to antiviral treatment and cirrhosis, liver cancer or transplants or death.

Some state Medicaid programs and prison systems still restrict treatment based on substance use or stage of liver disease.

Readily available clinical parameters can identify those at greatest risk for hepatocellular carcinoma.

Rates of liver complications were similar, but HIV-positive people had more non-liver cancers and non-liver-related deaths.

Homeless people, incarcerated individuals and people with mental health conditions achieved a high cure rate.

I have spent a lot of time and energy figuring out ways to smuggle medicines to people in need of them.

Ask Hep looks at drugs and supplements that may interact with direct-acting antivirals used to treat hepatitis C.

This finding from a study of people with both diseases underlines the importance of treating the virus.

Curing hep C slashes risk of death for those with liver cancer history

Ask Hep explains why people who are starting treatment for hepatitis C, should be tested for hepatitis B.

Sustained response to direct-acting antivirals prolonged survival by a year and a half.

This is according to an analysis of nearly 5,000 Italians recently treated for the virus.

Do you wonder if the medicines and other substances you take interact with each other? For more about this, read Ask Hep.

Large European study finds that more than 1 in 10 people with HIV acquire HCV again.

The argument has always been that the risk of damage from ribavirin’s toxicity is offset by its antiviral qualities.

Cure rates are high, but some young people already have advanced liver damage by the time they’re treated.